“A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD”. Journal of Carcinogenesis, vol. 24, no. 8s, Oct. 2025, pp. 542-6, https://doi.org/10.64149/J.Carcinog.24.8s.542-546.